Mag. Rainer Schultes
Born in 1973. Attorney in Austria since 2005.
| Back to index | |
| Fields of activity |
Intellectual Property Law including patent Law, in particular enforcement and defence of property rights in litigious proceedings; competition law, information technology, pharmaceutical law, medical device law, competition law
|
| Education |
1994-1998: University of Vienna, Faculty of Law
1997-1998: University of Urbino, Italy |
| Memberships |
Vienna Bar Association
Board Member of the Austrian Association for Intellectual Property and Copyright AIPPI, GRUR, AIGLI, LES, LIDC, INTA Italian Chamber of Commerce in Austria |
| Professional experience |
2001-2002: Associate at Weiss-Tessbach Rechtsanwälte GmbH
2002–2005: Associate at Gassauer-Fleissner Rechtsanwälte GmbH 2005–2008: Attorney at law at Gassauer-Fleissner Rechtsanwälte GmbH since 2008: Attorney at law at e│n│w│c Attorneys at Law, Vienna |
| Publications |
• eBay responsible for (some) trademark infringements, chemiereport 7/2011
• Software Patents Worldwide, Austrian Chapter, looseleaf, co-author with Heger, Weinzinger, KluwerLaw, 2011 • Information of patients: ECJ one step ahead, chemiereport 5/2011 • Trademarks on the move, chemiereport 3/2011 • Grey areas in design protection, Chemiereport 1/2011 • Income-tax reduction for the exploitation of inventions and the inventive step in Germany and Austria, ecolex 2010, 894 • „Thumbnails“ and „Keyword-Advertising“, Chemiereport 5/2010 • News on the scope of swiss type claims, ÖBl 2010, 172 • Gap in the patent protection for nutrinal supplements, Chemiereport 3/2010 • Licencability of TV-formats, Co-author with Demetz, ecolex 2010, 264 • CE-Mark – A lot of Books, a lot of Seals, Chemiereport 1/2010 • Re-packaging of parallel imported pharmaceuticals, Chemiereport 7/2009 • Parallel importation of pharmaceuticals into the USA , Co-author with Grünzweig, wbl wbl 2009, 437 • The suspensory effect with regard to cease and desist claims, ecolex 2009, 686 • Comment on OGH 17 Ob 26/08k – Pantoprazol I, ÖBl 2009, 191 • Comment on OGH 17 Ob 18/08h – Losartan, on the direct applicability of TRIPS, GRURInt 2009,612 • Mind the mark – or keep your trademark in mind, Chemiereport 3/2009 • Saving licences in case of insolvency– Co-author with Stossier, der Standard, 18. 3. 2009 • Anti-corruptive laws – Between criminal law and Medicinal Products Act, Chemiereport 1/2009 • Comment on OGH 17 Ob 6/08v – Bicalutamid II, equivalence of process-patents, GRURInt 2008,1047 • The train goes on! New power for process-patents - Chemiereport 7/2008 • Comment on Supreme Court 4Ob 27/08m - imitation of cigarette, ÖBl 2008, 325 • ”Patent law” and "licence agreements" in Straberger, Comunity law - Manual for the Austrian legal practice, [2008] • Explosive licences - Emerging new risks for breaches of competion law? Chemiereport 5/2008 • Patent-law liability of social insurance providers and the Social Security Association, ÖBl 2008, 116, co-author with Gassauer-Fleissner/Rittler • Ultimate destination appeal-court - Lack of legal-protection in patent litigation? Chemiereport 3/ 2008 • Pharmamarketing skating on thin ice, Chemiereport, 1/08 • Design protection without registration?, Protezione del disegno senza registrazione?, www.italcham.at • The Community Design in particular relation to Austria, ECTA Gazette no. 54, 2007 • Comment on Supreme Patent and Trademark Senate’s decision – Omeprazol, ÖBl 2006, 191 • Comment on Supreme Court decision on validity of Swiss Type Claims of Patents, ÖBl 2005, 86, co-author with Gassauer-Fleissner • The patent attorney is still necessary for the appropriate prosecution of an action, ÖBl 2002, 265, co-author with Gassauer-Fleissner |
| Languages |
German, English, Italian
|
| r.schultes@enwc.com | |
| Back to index |